CIN-type cancers are characterized by numerous chromosomal rearrangements and mutations in key genes like APC, KRAS, and TP53, and tend to be more aggressive, whereas MSI-type cancers exhibit a high mutation burden associated with defects in DNA mismatch repair, responding favorably to immune checkpoint inhibitors (58, 59). Here, KRAS is linked to cancer.